stoxline Quote Chart Rank Option Currency Glossary
Senseonics Holdings, Inc. (SENS)
0.47  -0.01 (-2.08%)    07-17 16:00
Open: 0.4772
High: 0.4889
Volume: 960,856
Pre. Close: 0.48
Low: 0.4627
Market Cap: 250(M)
Technical analysis
2024-07-17 5:30:13 PM
Short term     
Mid term     
Targets 6-month :  0.58 1-year :  0.68
Resists First :  0.49 Second :  0.58
Pivot price 0.42
Supports First :  0.41 Second :  0.36
MAs MA(5) :  0.47 MA(20) :  0.41
MA(100) :  0.48 MA(250) :  0.55
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  78.8 D(3) :  78.6
RSI RSI(14): 63.9
52-week High :  0.96 Low :  0.36
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SENS ] has closed below upper band by 18.4%. Bollinger Bands are 11.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.49 - 0.49 0.49 - 0.49
Low: 0.46 - 0.46 0.46 - 0.46
Close: 0.47 - 0.47 0.47 - 0.47
Company Description

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Headline News

Thu, 11 Jul 2024 Initiates Coverage on Senseonics (NYSE:SENS) - American Banking and Market News

Fri, 21 Jun 2024
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook - StockTitan

Mon, 13 May 2024
SENS Stock Earnings: Senseonics Holdings Meets EPS, Beats Revenue for Q1 2024 - MSN

Mon, 13 May 2024
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management - Business Wire

Mon, 13 May 2024
Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript - Seeking Alpha

Mon, 13 May 2024
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 528 (M)
Shares Float 504 (M)
Held by Insiders 6.3 (%)
Held by Institutions 13.3 (%)
Shares Short 47,390 (K)
Shares Short P.Month 49,320 (K)
Stock Financials
EPS -0.1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.1
Profit Margin -158.8 %
Operating Margin -312 %
Return on Assets (ttm) -28.8 %
Return on Equity (ttm) -84.8 %
Qtrly Rev. Growth 31.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.03
EBITDA (p.s.) -0.15
Qtrly Earnings Growth 0 %
Operating Cash Flow -72 (M)
Levered Free Cash Flow -78 (M)
Stock Valuations
PE Ratio -5.23
PEG Ratio -0.2
Price to Book value 4.69
Price to Sales 12.45
Price to Cash Flow -3.43
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android